The quality-adjusted life-years loss due to serogroup B invasive meningococcal disease in Spain

Andrea García1, Laura A Vallejo-Aparicio1, Najida Begum2

  • 1GSK, Tres Cantos, Spain.

Vaccine
|August 15, 2024
PubMed
Abstract

Insights

The humanistic burden of serogroup B invasive meningococcal disease (MenB-IMD) in Spain is substantial, primarily driven by long-term sequelae in patients and their families. This study quantifies the significant quality-adjusted life-year (QALY) loss associated with MenB-IMD.

Area of Science:

  • Public Health
  • Epidemiology
  • Health Economics

Background:

  • Limited evidence exists on the humanistic burden of serogroup B invasive meningococcal disease (MenB-IMD) in Spain.
  • This study addresses the paucity of data by estimating the societal impact of MenB-IMD.

Purpose of the Study:

  • To estimate the total quality-adjusted life-year (QALY) loss due to MenB-IMD in Spain from a societal perspective.
  • To quantify the direct and indirect humanistic burden of MenB-IMD on patients and their families/caregivers.

Main Methods:

  • An incidence-based Excel tool adapted for the Spanish setting was utilized.
  • QALY losses were estimated over a lifetime horizon, incorporating direct and indirect impacts.
  • Discount rates and sensitivity analyses were applied to assess uncertainty.

Main Results:

  • A hypothetical cohort of 142 MenB-IMD cases resulted in a total discounted QALY loss of 572.44 (4.03/case).
  • Direct loss (patients) accounted for 81.2% and indirect loss (families/caregivers) for 18.8% of the total.
  • Sequelae significantly drove QALY loss (60.5% for patients, 84.6% for caregivers); children under 5 years old represented 47.8% of the total loss.

Conclusions:

  • The humanistic burden of MenB-IMD is substantial, largely influenced by long-term sequelae.
  • Both patients and their relatives/caregivers experience significant quality-of-life impacts.
  • Findings highlight the importance of addressing the sequelae of MenB-IMD to mitigate societal burden.

Related Concept Videos

Infectious Diseases and Their Occurrence01:28

Infectious Diseases and Their Occurrence

Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...